GM Advisory Group’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
GM Advisory Group's CELL Position: Q2 2022 in Review
GM Advisory Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 12,300 shares — an estimated $87K sold.
GM Advisory Group first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $2.17M in Q2 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.
- GM Advisory Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- GM Advisory Group sold 12,300 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $87K.
- GM Advisory Group first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
- GM Advisory Group's PhenomeX Inc. Common Stock position peaked at $2.17M in Q2 2021.
- 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.
Based on GM Advisory Group's 13F filing for Q2 2022, filed 15 Aug 2022.